CWM
OGN icon

C2C Wealth Management’s Organon & Co OGN Stock Holding History

C2C Wealth Management’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-28,722
Closed -$481K – 190
2023
Q3 		$481K Sell
28,722
-500
-2% -$10.4K 0.07% 153
2023
Q2 		$596K Buy
+29,222
New +$635K 0.08% 131

Other funds holding OGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SSM
Sound Shore Management Greenwich, Connecticut $3.25B AUM 28.47% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SPC
Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return

C2C Wealth Management's OGN Position: Q4 2023 in Review

C2C Wealth Management sold out of Organon & Co (OGN) in Q4 2023, closing a stake of 28,722 shares — an estimated $481K sold.

C2C Wealth Management first reported a position in OGN in Q2 2023 and held it in 2 quarters. The position peaked at $596K in Q2 2023. 719 funds tracked by Wall St. Rank hold OGN as of Q4 2023.

  • C2C Wealth Management reported no remaining Organon & Co position as of Q4 2023 after selling out during the quarter.
  • C2C Wealth Management sold 28,722 Organon & Co shares in Q4 2023, an estimated $481K.
  • C2C Wealth Management first reported a position in Organon & Co in Q2 2023 and held it in 2 quarters.
  • C2C Wealth Management's Organon & Co position peaked at $596K in Q2 2023.
  • 719 funds tracked by Wall St. Rank held Organon & Co as of Q4 2023.

Based on C2C Wealth Management's 13F filing for Q4 2023, filed 13 Feb 2024.